financetom
Business
financetom
/
Business
/
Update: Rivian Automotive Unveils New Vehicles Built on New Midsize Platform
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Rivian Automotive Unveils New Vehicles Built on New Midsize Platform
Mar 8, 2024 5:35 AM

08:13 AM EST, 03/08/2024 (MT Newswires) -- (Updates with details on Georgia plant construction halt in fourth paragraph.)

Rivian Automotive ( RIVN ) on Thursday unveiled R2, R3 and R3x vehicles built on its new midsize platform.

R2 is a mid-size sports utility vehicle, with pricing expected to start around $45,000. It is now available for reservation in the US and deliveries are expected to begin in H1 of 2026, the company said.

Deliveries of midsize crossover R3 and its performance variant R3X are expected to begin after R2, the company said, adding that R3 will be priced below R2.

Meanwhile, the company said it is pausing plans to build a new factory in Georgia in a bid to save more than $2.25 billion in expenses.

Rivian shares were about 1% higher in premarket trading on Friday.

Price: 12.62, Change: +0.11, Percent Change: +0.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Solaris Reports Exploration Results from Celestina Target In Ecuador
Solaris Reports Exploration Results from Celestina Target In Ecuador
Mar 11, 2026
08:30 AM EDT, 09/10/2024 (MT Newswires) -- Solaris Resources ( SLSR ) , trading at the low end of its 52 week trading ranges in both Canada and the U.S., reported Tuesday recent results from the Celestina target area as part of its continuing district exploration program at the Warintza project in Ecuador. A statement noted Celestina lies within the...
Biohaven meets main trial goal for rare genetic disease treatment
Biohaven meets main trial goal for rare genetic disease treatment
Mar 11, 2026
Sept 23 (Reuters) - Biohaven ( BHVN ) said on Monday it had met the main goal in a study evaluating its treatment in patients with an inherited disease that mainly affects the brain. (Reporting by Christy Santhosh; Editing by Anil D'Silva) ...
Top Premarket Decliners
Top Premarket Decliners
Mar 11, 2026
07:40 AM EDT, 09/23/2024 (MT Newswires) -- Chijet Motor ( CJET ) shares fell 14% pre-bell Monday, reversing gains from the previous session. Revance Therapeutics ( RVNC ) shares retreated 12%, following a muted session. Anebulo Pharmaceuticals ( ANEB ) shares were down 12%, reversing from Friday's 39% rise. Gaxos.ai ( GXAI ) shares dropped 10% after Friday's 3.9% gain....
Volkswagen CEO expects significant concessions from unions in crunch talks
Volkswagen CEO expects significant concessions from unions in crunch talks
Mar 11, 2026
FRANKFURT (Reuters) - Volkswagen's CEO expects labour unions to make proposals on how to cut costs and close a gap with competitors, two days before talks over plant closures and new wage deals. Europe's top carmaker earlier this month cancelled long-standing job security schemes and said it was considering plant closures in its home market for the first time. This...
Copyright 2023-2026 - www.financetom.com All Rights Reserved